BRCA2 and ovarian carcinoma: Germline (g) mutations in either the BRCA1 or BRCA2 genes render individuals at high life-time risk of breast and ovarian cancer (Gudmundsdottir and Ashworth, 2006) and these subsequent cancers may have HRR deficiency (HRD).